Cytokinetics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $3.2M | 37k | 85.19 |
| 2026-03-31 | $2.1M | 32k | 65.91 |
| 2025-12-31 | $2.0M | 32k | 63.54 |
| 2025-09-30 | $1.8M | 32k | 54.96 |
| 2025-06-30 | $1.2M | 35k | 33.04 |
| 2025-03-31 | $1.4M | 35k | 40.19 |
| 2024-12-31 | $1.7M | 36k | 47.04 |
| 2024-09-30 | $1.9M | 36k | 52.80 |
| 2024-06-30 | $1.9M | 35k | 54.18 |
| 2024-03-31 | $2.2M | 31k | 70.11 |
| 2023-12-31 | $783k | 9.4k | 83.49 |
| 2023-09-30 | $273k | 9.3k | 29.46 |
| 2023-06-30 | $251k | 7.7k | 32.62 |
| 2023-03-31 | $227k | 6.4k | 35.19 |
| 2022-12-31 | $272k | 6.4k | 42.20 |
| 2022-09-30 | $311k | 6.4k | 48.31 |
| 2022-06-30 | $241k | 6.1k | 39.22 |
| 2022-03-31 | $226k | 6.1k | 36.78 |
| 2021-12-31 | $280k | 6.1k | 45.57 |
| 2021-09-30 | $220k | 6.1k | 35.80 |
| 2021-06-30 | $112k | 5.7k | 19.81 |
| 2021-03-31 | $132k | 5.7k | 23.34 |
| 2020-12-31 | $118k | 5.7k | 20.87 |
| 2020-09-30 | $122k | 5.7k | 21.57 |
| 2020-06-30 | $110k | 4.7k | 23.48 |
| 2020-03-31 | $55k | 4.7k | 11.74 |
| 2019-12-31 | $50k | 4.7k | 10.67 |
| 2019-09-30 | $53k | 4.7k | 11.31 |
| 2019-06-30 | $53k | 4.7k | 11.31 |
| 2019-03-31 | $30k | 3.6k | 8.23 |
| 2018-12-31 | $23k | 3.6k | 6.31 |
| 2018-09-30 | $36k | 3.6k | 9.87 |
| 2018-06-30 | $30k | 3.6k | 8.23 |
| 2018-03-31 | $26k | 3.6k | 7.13 |
| 2017-12-31 | $30k | 3.6k | 8.23 |
| 2017-09-30 | $54k | 3.6k | 14.81 |
| 2017-06-30 | $44k | 3.6k | 12.06 |
| 2017-03-31 | $36k | 2.8k | 12.69 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors